HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aftab A Ansari Selected Research

Norgestrienone (A 301)

4/2004Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aftab A Ansari Research Topics

Disease

59Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
01/2022 - 01/2002
53Infections
11/2021 - 01/2002
15Cholangitis
01/2017 - 08/2007
12Autoimmune Diseases (Autoimmune Disease)
12/2018 - 01/2002
10Inflammation (Inflammations)
01/2020 - 11/2002
10Acquired Immunodeficiency Syndrome (AIDS)
01/2015 - 01/2004
9HIV Infections (HIV Infection)
01/2018 - 11/2004
8Liver Diseases (Liver Disease)
01/2017 - 12/2002
8Disease Progression
06/2015 - 01/2002
6Neoplasms (Cancer)
05/2017 - 08/2004
5Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2018 - 06/2008
4Sclerosing Cholangitis
01/2020 - 11/2002
4Colitis
03/2013 - 03/2009
4Cardiomyopathies (Cardiomyopathy)
09/2010 - 12/2002
3Viremia
11/2021 - 03/2007
3Rheumatic Diseases (Rheumatism)
01/2020 - 02/2008
3Virus Diseases (Viral Diseases)
05/2014 - 10/2011
2COVID-19
11/2020 - 01/2020
2Cytokine Release Syndrome
01/2020 - 01/2020
2Liver Cirrhosis (Hepatic Cirrhosis)
01/2020 - 02/2013
2T-Cell Leukemia (Leukemia, T Cell)
11/2016 - 06/2014
2Disease Susceptibility (Diathesis)
01/2016 - 09/2003
2Persistent Infection
03/2014 - 06/2008
2Communicable Diseases (Infectious Diseases)
01/2014 - 06/2008
2Heart Failure
09/2010 - 01/2008
1Urinary Tract Infections (Urinary Tract Infection)
01/2022
1Connective Tissue Diseases (Connective Tissue Disease)
01/2021
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2021
1Guillain-Barre Syndrome
01/2021
1Vasculitis (Vasculitides)
01/2021
1Arthritis (Polyarthritis)
01/2021
1Coronavirus Infections
01/2020

Drug/Important Bio-Agent (IBA)

32AntibodiesIBA
01/2021 - 12/2002
17CytokinesIBA
12/2017 - 01/2004
15AntigensIBA
12/2018 - 01/2003
14AutoantibodiesIBA
09/2013 - 01/2002
11XenobioticsIBA
11/2014 - 11/2003
10AutoantigensIBA
05/2017 - 01/2002
10Proteins (Proteins, Gene)FDA Link
12/2014 - 10/2002
9Monoclonal AntibodiesIBA
01/2018 - 03/2009
7Pyruvate Dehydrogenase Complex (Dehydrogenase Complex, Pyruvate)IBA
01/2022 - 05/2003
7ChemokinesIBA
12/2017 - 09/2005
7Immunoglobulin M (IgM)IBA
01/2017 - 01/2003
7LigandsIBA
01/2015 - 09/2005
7Transforming Growth Factor beta Receptors (TGF beta Receptors)IBA
10/2012 - 08/2006
6Oxidoreductases (Dehydrogenase)IBA
09/2013 - 12/2003
5VaccinesIBA
11/2020 - 09/2003
5Peptides (Polypeptides)IBA
01/2018 - 06/2003
5IntegrinsIBA
10/2016 - 01/2011
5Immunoglobulins (Immunoglobulin)IBA
03/2015 - 02/2005
5InterleukinsIBA
05/2014 - 01/2004
5Pyruvic Acid (Pyruvate)IBA
09/2013 - 12/2003
4Immunoglobulin G (IgG)IBA
11/2021 - 01/2003
4Antiviral Agents (Antivirals)IBA
01/2020 - 01/2004
4Interleukin-17 (Interleukin 17)IBA
05/2014 - 02/2009
4Interferon-gamma (Interferon, gamma)IBA
05/2014 - 01/2004
4Interleukin-12 (IL 12)IBA
05/2014 - 09/2010
42-octynoic acidIBA
01/2013 - 05/2005
4EpitopesIBA
10/2011 - 01/2002
4Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
03/2009 - 01/2004
3vedolizumabIBA
01/2018 - 01/2018
3KIR ReceptorsIBA
01/2014 - 03/2009
3DNA (Deoxyribonucleic Acid)IBA
01/2011 - 01/2002
3Interleukin-2 Receptor alpha SubunitIBA
01/2009 - 01/2004
2Peptide Hydrolases (Proteases)FDA Link
01/2020 - 01/2002
2Interleukin-7 (Interleukin 7)IBA
01/2018 - 03/2007
2SteroidsIBA
05/2017 - 12/2014
2Chemokine ReceptorsIBA
01/2017 - 09/2005
2LectinsIBA
01/2015 - 10/2008
2Nitric Oxide (Nitrogen Monoxide)FDA Link
12/2014 - 10/2003
2EnzymesIBA
11/2014 - 07/2011
2interleukin-21 (interleukin 21)IBA
07/2014 - 11/2012
2Pharmaceutical PreparationsIBA
06/2014 - 05/2009
2Therapeutic UsesIBA
02/2013 - 07/2010
2Interleukin-6 (Interleukin 6)IBA
07/2010 - 03/2009
2Biomarkers (Surrogate Marker)IBA
05/2009 - 09/2008
2Immunoglobulin A (IgA)IBA
03/2009 - 05/2004
2N 30IBA
03/2009 - 04/2006
2Sialic Acid Binding Immunoglobulin-like LectinsIBA
10/2008 - 11/2007
2Hormones (Hormone)IBA
09/2008 - 02/2002
2Messenger RNA (mRNA)IBA
11/2007 - 11/2002
2Telomerase (Telomerase Reverse Transcriptase)IBA
08/2007 - 04/2002
2CaspasesIBA
05/2004 - 01/2002
2Antigen-Antibody Complex (Immune Complex)IBA
01/2003 - 01/2002
1RNA (Ribonucleic Acid)IBA
01/2021
1Immunomodulating AgentsIBA
11/2020
1tocilizumab (atlizumab)FDA Link
01/2020
1Antirheumatic Agents (DMARD)IBA
01/2020
1Polysaccharides (Glycans)IBA
01/2020
1Immunosuppressive Agents (Immunosuppressants)IBA
01/2020
1SugarsIBA
01/2020
1Antimalarials (Antimalarial Agents)IBA
01/2020
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
12/2018

Therapy/Procedure

12Therapeutics
11/2021 - 01/2002
4Highly Active Antiretroviral Therapy (HAART)
01/2021 - 06/2005
3Immunotherapy
05/2017 - 06/2008
2Art Therapy
11/2021 - 01/2017
2Ligation
11/2013 - 10/2011
2Drug Therapy (Chemotherapy)
01/2012 - 01/2002
1Biological Therapy
01/2020